BOVIE MEDICAL CORPORATION – Trademark Portfolio
Entity Type: 03
BOVIE MEDICAL CORPORATION holds 30 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 28 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include APYX, BOVIE, J-PLASMA, RENUVION, and COOL-COAG. The owner is based in Clearwater, FL.
5115 Ulmerton Road
Attn: Mr. Moshe Citronowicz
Clearwater, FL 33760
Showing of trademarks Trademarks
Trademark Classifications
BOVIE MEDICAL CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does BOVIE MEDICAL CORPORATION have?
BOVIE MEDICAL CORPORATION has 30 U.S. trademarks filed with the USPTO. Of these, 12 registered, 10 abandoned, 8 cancelled.
What trademark classes does BOVIE MEDICAL CORPORATION file in?
BOVIE MEDICAL CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BOVIE MEDICAL CORPORATION's most well-known trademarks?
BOVIE MEDICAL CORPORATION's registered trademark portfolio includes well-known marks such as APYX, BOVIE, J-PLASMA, RENUVION, and COOL-COAG. These are among 12 currently registered trademarks in the portfolio.
What is BOVIE MEDICAL CORPORATION's trademark registration success rate?
BOVIE MEDICAL CORPORATION has a 40% trademark registration rate, with 12 out of 30 resolved applications resulting in successful registration. Currently, 0 applications are pending review.